Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Clinical and Experimental Pharmacology and Physiology Année : 2016

Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems

Résumé

Extracorporeal membrane oxygenation (ECMO) procedure used in the management of patients with cardiac and/or respiratory failure could modify drugs pharmacokinetics (PK) properties. Studying the impact of ECMO devices on drugs PK is warranted to optimize dosage and ensure clinical outcomes. We aimed to characterize the behavior of four cephalosporins and three carbapenems commonly used in an ECMO circuit with an in-vitro approach focusing on the coated tubing, support of the extracorporeal circulation. Results suggest that these antibiotics are not sequestrated by ECMO tubing. This pilot mechanistic study provides original data that will contribute to improve our understanding of the impact of ECMO on the PK of drugs commonly used in intensive care unit patients.
Fichier principal
Vignette du fichier
Should we fear tubing adsorption of antibacterial drugs_accepted.pdf (161.86 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01255854 , version 1 (08-02-2016)

Identifiants

Citer

Camille Tron, Cyril Leven, Pierre Fillâtre, Nicolas Maillard, Nicolas Nesseler, et al.. Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems. Clinical and Experimental Pharmacology and Physiology, 2016, 43 (2), pp.281-283. ⟨10.1111/1440-1681.12527⟩. ⟨hal-01255854⟩
330 Consultations
280 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More